Lung Vascular Endothelial-Targeted Nanoparticle Formulation for Suppre...

Innovative IV DDS delivering a natural anti-inflammatory & anti-thrombotic compound directly to lung…

A New Therapeutic Approach for Renal Failure Associated with Joubert S...

Application of JAK Inhibitors for Nephronophthisis in Ciliopathies

Premedication for Infusion-Related Reactions (IRR) to Antibody Therape...

PAF Inhibition for Anti-Histamine-Resistant IRR - Targeting Myeloid Cell-Mediated Hypersensitivity …

FAPα‑Targeted Substrate‑Type Radiotheranostic Agent

A novel dual‑targeting compound that exploits FAPα enzymatic activity to target the tumor stroma whi…

Next-Generation Nucleic Acid Therapeutics Targeting Cancer-Specific R-...

A Binding Blocker Oligonucleotide (BBO) technology that selectively inhibits specific domains respon…

A Novel Class of Ferroptosis Inhibitors Based on Silicon-Containing Po...

Candidate compounds offering a new therapeutic approach for Alzheimer’s disease, Parkinson’s disease…

Development of Novel Therapeutic Agent for LKB1-Inactivated Lung Cance...

An innovative therapeutic approach for refractory LKB1-inactivated lung cancer using next-generation…

Small molecule compounds that facilitate drug delivery to the brain

A Next-Generation Platform Technology Dramatically Enhancing Brain Delivery of Small and Medium-Mole…

Anti-PF4 mAb: selectively targeting tumor-associated Tregs

Avoiding immune-related adverse events (irAEs) by locally inhibiting Th1-Treg differentiation in the…

Decoy formulations of the SARS-CoV-2 virus using a modified ACE2 recep...

Researchers have successfully engineered a high-affinity modified ACE2 receptor that is resistant to…